Position in RNXT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,074
+$1,569 QoQ
Shares Held
17,896
-8.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $12,245,110 across 97 Biotechnology names. RNXT ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
22,096 | $1,248,203 | |
| 2 | INCY |
Incyte Corp
|
11,772 | $1,107,980 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
23,779 | $956,629 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,135 | $876,946 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
11,908 | $627,789 | |
| 6 | ABVX |
Abivax S.A.
|
3,936 | $438,273 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
6,851 | $345,564 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
9,885 | $328,379 |
All Filings in RNXT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,074 | 17,896 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,505 | 19,649 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $28,713 | 21,835 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $15,098 | 11,704 | Shares | Sole | 2025-02-14 | |
| 2021-09-30 | $108,381 | 17,944 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||